All > Glaucoma > Latisse

Bimatoprost Ophthalmic for Ocular Hypertension

Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Ocular Hypertension+1 MoreBimatoprost Ophthalmic - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether a new glaucoma medication is as effective as the current standard medication.

Eligible Conditions
  • Ocular Hypertension
  • Glaucoma

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Similar Trials

1
Kinezodianone R hydrochloride
1
OTX-TIC high dose Travoprost Intracameral Implant
2
Bimatoprost (SR)

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: up to Week12

up to Week12
Change from baseline (Day 1) to Week 2, Week 6, and Week 12 in IOP.

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
Kinezodianone R hydrochloride
2
OTX-TIC high dose Travoprost Intracameral Implant
3
Bimatoprost (SR)

Trial Design

2 Treatment Groups

Lumigan
1 of 2
T4032
1 of 2

Active Control

Experimental Treatment

500 Total Participants · 2 Treatment Groups

Primary Treatment: Bimatoprost Ophthalmic · No Placebo Group · Phase 3

T4032
Drug
Experimental Group · 1 Intervention: Bimatoprost Ophthalmic · Intervention Types: Drug
Lumigan
Drug
ActiveComparator Group · 1 Intervention: Bimatoprost Ophthalmic · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to week12

Who is running the clinical trial?

Laboratoires TheaLead Sponsor
51 Previous Clinical Trials
5,521 Total Patients Enrolled
6 Trials studying Ocular Hypertension
1,754 Patients Enrolled for Ocular Hypertension

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have open-angle glaucoma or ocular hypertension.

Who else is applying?

What state do they live in?
Pennsylvania100.0%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%
Why did patients apply to this trial?
  • "I am 73 years old female I have catarac in my eyes I have been operete once on the eye but I can't even from distance"
How many prior treatments have patients received?
1100.0%
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top